Seasonal influenza vaccination and antiviral use in EU/EEA Member States
Overview of vaccine recommendations for 2017–2018 and vaccination coverage rates for 2015–2016 and 2016–2017 influenza seasons.
Seasonal influenza vaccination in Europe – Vaccination recommendations and coverage rates for 2013-14 and 2014-15
Overview of vaccination recommendations and coverage rates in the EU Member States for the 2013–14 and 2014–15 influenza seasons.
Risk assessment: seasonal influenza 2011-2012 in Europe
The virological influenza pattern observed was not consistent enough to make a clear prediction for the 2011-2012 season in Europe. In general, the findings on the impact of influenza in the southern hemisphere in 2011 were reassuring for Europe, and the match of the A(H3N2) viruses with the vaccine was considered good.
Seasonal influenza vaccination in Europe – Vaccination recommendations and coverage rates for 2012–13
This report provides an update on seasonal influenza immunisation policies and vaccination coverage rates in EU/EEA Member States for the 2012–13 influenza season.
Early 2016/17 vaccine effectiveness estimates against influenza A(H3N2): I-move multicentre case control studies at primary care and hospital levels in Europe
Kissling, E., Rondy, M., Kaić, B., Horváth, J.K., Ferenczi, A., Oroszi, B., Vizler, Z., Hercegh, É., Szala, B., Alfonsi, V., Bella, A., Paradowska-Stankiewicz, I., Brydak, L., Nunes, B., Machado, A., Rodrigues, A.P., Gomez, V., Kislaya, I., Uva, M.S., Guiomar, R., Pechirra, P., Cristóvao, P., Conde, P., Costa, I., Pitigoi, D., Lupulescu, E., Ivanciuc, A.E., Lazar, M., Cherciu, C.M., Larrauri, A., Gherasim, A., Pozo, F., Comas, L.G., Carril, F.G., Castilla, J., Quinones, C., Giménez, J., Castrillejo, D., Amores, M.O., Falchi, A., Vilcu, A.-M., Souty, C., Blanchon, T., Behillil, S., Enouf, V., Cité, S.P., Lina, B., Valette, M., Reuss, A., Buda, S., Prahm, K., Wedde, M., Martin, M., Biere, B., O’Donnell, J., Domegan, L., Kelly, A., Joyce, M., Collins, C., De Gascun, C., Connell, J., Tuite, G., Duffy, M., Moran, J., Hogg, B., Dunford, L., Brytting, M., Zakikhany, K., De Lange, M., Donker, G., Johansen, K., Penttinen, P., Syrjänen, R., Nohynek, H., Haveri, A., Launay, O., Galtier, F., Vanems, P., Lainé, F., Lenzi, N., Antmann, K., Nagy, K., Gefenaite, G., Kuliešė, M., Mickiene, A., Jancoriene, L., Zablockiene, B., Damuleviciene, G., Grimalauskaite, R., Bagdonas, A., Casado, I., Díaz-González, J., Castilla, J., Nitescu, M., Ceausu, E., Bejan, C., Marbus, S.
First steps in the design of a system to monitor vaccine effectiveness during seasonal and pandemic influenza in EU/EEA Member States
Valenciano, M., Ciancio, B., Moren, A.
ECDC Vaccine Scheduler
- Hepatitis A
- Hepatitis B
- Human papillomavirus infection
- Influenza in humans, seasonal
- Invasive Haemophilus influenzae disease
- Meningococcal disease
- Pneumococcal disease
- Prevention and control
- Rotavirus infection
- Tick-borne diseases
Seasonal influenza vaccination in Europe – Vaccination recommendations and coverage rates for eight influenza seasons (2007–2008 to 2014–2015)
Vaccination recommendations and coverage rates in the EU Member States for eight influenza seasons: 2007–2008 to 2014–2015.
Questions and answers about antivirals
Frequently asked questions about the use of antivirals for prevention and treatment of influenza; What are the uses of antivirals against seasonal influenza? Which are the antivirals we use in Europe against seasonal influenza and who should get them? If antivirals are so good why don’t doctors give them out more often? Do people who have been immunized against influenza need antivirals?